Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

5.42
Delayed Data
As of 3:59pm ET
 -0.41 / -7.03%
Today’s Change
4.45
Today|||52-Week Range
14.93
-34.78%
Year-to-Date
Why ZIOPHARM Oncology's Stock Broke Down in July
Aug 11 / MotleyFool.com - Paid Partner Content
Intrexon (XON) Reports Wider Loss in Q2, Revenues Increase
Aug 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close5.83
Today’s open5.78
Day’s range5.24 - 5.86
Volume1,971,127
Average volume (3 months)2,377,407
Market cap$768.0M
Dividend yield--
Data as of 3:59pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-209.68%
Earnings growth (this year)-19.37%
Earnings growth (next 5 years)--
Revenue growth (last year)+215.51%
P/E ratioNM
Price/Sales240.58
Price/Book8.79

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...-0.96-4.95%
HRTXHeron Therapeutics I...-1.03-4.93%
SGNTSagent Pharmaceutica...-0.01-0.05%
INSMInsmed Inc-0.73-5.44%
Data as of 3:59pm ET, 08/24/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$4.3M
Annual profit (last year)-$120.1M
Net profit margin-2,772.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Managing Director
Laurence James Neil Cooper
COO, Secretary, Chief Legal Officer &
Executive VP
Caesar J. Belbel
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers

Search for Jobs